ROCKVILLE, Md. and BEIJING, May 2,
2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq:
CASI), a U.S. biopharmaceutical company focused on developing and
commercializing innovative therapeutics and pharmaceutical
products, today announced the Company will host a conference call
reviewing the financial results for the first quarter of 2022, at
8:00 a.m. EST on Thursday, May
12th, 2022.
On the call, CASI's Chairman & CEO will provide an update on
the Company's business and upcoming milestones. The conference call
can be accessed by dialing 1-866-218-2402 (U.S.) or 1-412-902-6605
(international) and ask to be joined into the CASI Pharmaceuticals
call to listen to the live conference call. Confirmation
#10165613.
This call will be recorded and available for replay by dialing
1-877-344-7529 (U.S.) or 1-412-317-0088 (international) and enter
2360248 to access the replay.
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company
focused on developing and commercializing innovative therapeutics
and pharmaceutical products in China, the United
States, and throughout the world. The Company is focused on
acquiring, developing, and commercializing products that augment
its hematology oncology therapeutic focus as well as other areas of
unmet medical need. The Company intends to execute its plan to
become a leader by launching medicines in the greater China market leveraging the Company's
China-based regulatory and
commercial competencies and its global drug development expertise.
The Company's operations in China
are conducted through its wholly-owned subsidiary, CASI
Pharmaceuticals (China) Co., Ltd.,
which is located in Beijing,
China. The Company has built a commercial team of more than
100 hematology and oncology sales and marketing specialists based
in China. More information on CASI
is available at www.casipharmaceuticals.com.
COMPANY
CONTACT:
Rui Zhang
CASI
Pharmaceuticals, Inc.
240.864.2643
ir@casipharmaceuticals.com
|
INVESTOR
CONTACT:
Xuan Yang
Solebury
Trout
646.378.2975
xyang@soleburytrout.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-report-first-quarter-2022-financial-results-and-host-conference-call-may-12-2022-301536848.html
SOURCE CASI Pharmaceuticals, Inc.